相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Leveraging macrophages for cancer theranostics
Lu Liu et al.
ADVANCED DRUG DELIVERY REVIEWS (2022)
Clinical relevance of tumour-associated macrophages
Mikael J. Pittet et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2022)
Conjugating Ligands to an Equilibrated Nanoparticle Protein Corona Enables Cell Targeting in Serum
Benjamin Stordy et al.
CHEMISTRY OF MATERIALS (2022)
Nanomedicine enables spatiotemporally regulating macrophage-based cancer immunotherapy
Yong-Dan Zhao et al.
BIOMATERIALS (2021)
Tailoring Materials for Modulation of Macrophage Fate
Jinhua Li et al.
ADVANCED MATERIALS (2021)
Harnessing and Enhancing Macrophage Phagocytosis for Cancer Therapy
Siqi Chen et al.
FRONTIERS IN IMMUNOLOGY (2021)
Fullerenols boosting the therapeutic effect of anti-CD47 antibody to trigger robust anti-tumor immunity by inducing calreticulin exposure
Kui Chen et al.
NANO TODAY (2021)
A siRNA-Assisted Assembly Strategy to Simultaneously Suppress Self and Upregulate Eat-Me Signals for Nanoenabled Chemo-Immunotherapy
Yuxi Zhang et al.
ACS NANO (2021)
Detachable Liposomes Combined Immunochemotherapy for Enhanced Triple-Negative Breast Cancer Treatment through Reprogramming of Tumor-Associated Macrophages
Mingshu Chen et al.
NANO LETTERS (2021)
Macrophage-Mediated Tumor Cell Phagocytosis: Opportunity for Nanomedicine Intervention
Xuefei Zhou et al.
ADVANCED FUNCTIONAL MATERIALS (2021)
Responsive Exosome Nano-bioconjugates for Synergistic Cancer Therapy
Weidong Nie et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity
Christina A. von Roemeling et al.
NATURE COMMUNICATIONS (2020)
Treatment of severe sepsis with nanoparticulate cell-free DNA scavengers
Jianati Dawulieti et al.
SCIENCE ADVANCES (2020)
M2-Like Tumor-Associated Macrophage-Targeted Codelivery of STAT6 Inhibitor and IKKβ siRNA Induces M2-to-M1 Repolarization for Cancer Immunotherapy with Low Immune Side Effects
Hong Xiao et al.
ACS CENTRAL SCIENCE (2020)
Engineering Macrophages for Cancer Immunotherapy and Drug Delivery
Yuqiong Xia et al.
ADVANCED MATERIALS (2020)
Nanoscale Metal-Organic Framework Co-delivers TLR-7 Agonists and Anti-CD47 Antibodies to Modulate Macrophages and Orchestrate Cancer Immunotherapy
Kaiyuan Ni et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)
Nanoparticle-Enabled Dual Modulation of Phagocytic Signals to Improve Macrophage-Mediated Cancer Immunotherapy
Ya-Ru Zhang et al.
SMALL (2020)
Lipid-based phagocytosis nanoenhancer for macrophage immunotherapy
Anujan Ramesh et al.
NANOSCALE (2020)
Improving the efficacy of osteosarcoma therapy: combining drugs that turn cancer cell 'don't eat me' signals off and 'eat me' signals on
Suchismita Mohanty et al.
MOLECULAR ONCOLOGY (2019)
Harnessing innate immunity in cancer therapy
Olivier Demaria et al.
NATURE (2019)
Metabolic rewiring of macrophages by CpG potentiates clearance of cancer cells and overcomes tumor-expressed CD47-mediated 'don't-eat-me' signal
Mingen Liu et al.
NATURE IMMUNOLOGY (2019)
In Situ Dendritic Cell Vaccine for Effective Cancer Immunotherapy
Weijing Yang et al.
ACS NANO (2019)
Phagocytosis checkpoints as new targets for cancer immunotherapy
Mingye Feng et al.
NATURE REVIEWS CANCER (2019)
Macrophages as regulators of tumour immunity and immunotherapy
David G. DeNardo et al.
NATURE REVIEWS IMMUNOLOGY (2019)
Quantifying the Ligand-Coated Nanoparticle Delivery to Cancer Cells in Solid Tumors
Qin Dai et al.
ACS NANO (2018)
Immunogenic chemotherapy: Dose and schedule dependence and combination with immunotherapy
Junjie Wu et al.
CANCER LETTERS (2018)
The fluorination effect of fluoroamphiphiles in cytosolic protein delivery
Zhenjing Zhang et al.
NATURE COMMUNICATIONS (2018)
Programmed cell removal by calreticulin in tissue homeostasis and cancer
Mingye Feng et al.
NATURE COMMUNICATIONS (2018)
Dual Targeting of Innate and Adaptive Checkpoints on Tumor Cells Limits Immune Evasion
Xiaojuan Liu et al.
CELL REPORTS (2018)
CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin's Lymphoma
Ranjana Advani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Calreticulin Release at an Early Stage of Death Modulates the Clearance by Macrophages of Apoptotic Cells
Rim Osman et al.
FRONTIERS IN IMMUNOLOGY (2017)
Degradability and Clearance of Silicon, Organosilica, Silsesquioxane, Silica Mixed Oxide, and Mesoporous Silica Nanoparticles
Jonas G. Croissant et al.
ADVANCED MATERIALS (2017)
Immunogenic cell death in cancer and infectious disease
Lorenzo Galluzzi et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma
Abhishek D. Garg et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
CD47 blockade triggers T cell-mediated destruction of immunogenic tumors
Xiaojuan Liu et al.
NATURE MEDICINE (2015)
Danger signalling during cancer cell death: origins, plasticity and regulation
A. D. Garg et al.
CELL DEATH AND DIFFERENTIATION (2014)
Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response
Diane Tseng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Engineered SIRPα Variants as Immunotherapeutic Adjuvants to Anticancer Antibodies
Kipp Weiskopf et al.
SCIENCE (2013)
Biomolecular coronas provide the biological identity of nanosized materials
Marco P. Monopoli et al.
NATURE NANOTECHNOLOGY (2012)
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
Stephen B. Willingham et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47
Mark P. Chao et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis
Siddhartha Jaiswal et al.
CELL (2009)
CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
Ravindra Majeti et al.
CELL (2009)
Functions and molecular mechanisms of the CD47-SIRPα signalling pathway
Takashi Matozaki et al.
TRENDS IN CELL BIOLOGY (2009)
Calreticulin exposure dictates the immunogenicity of cancer cell death
Michel Obeid et al.
NATURE MEDICINE (2007)
Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte
SJ Gardai et al.
CELL (2005)
Flow cytometric quantitative determination of ingestion by phagocytes needs the distinguishing of overlapping populations of binding and ingesting cells
J Nuutila et al.
CYTOMETRY PART A (2005)
Signal-regulatory protein α (SIRPα) but not SIRPβ is involved in T-cell activation, binds to CD47 with high affinity, and is expressed on immature CD34+CD38- hematopoietic cells
M Seiffert et al.
BLOOD (2001)
分享论文
